Genetic Technologies Limited v. General Genetics Corporation
1:13-cv-00055
Overview
Parties
Defendant
General Genetics Corporation NPE (Individual / Inventor)
Represented By
0 Attorneys ListedPlaintiff
Genetic Technologies Limited NPE (University / Research)
Represented By
1 Attorneys ListedKlehr, Harrison, Harvey, Branzburg & Ellers
Klehr, Harrison, Harvey, Branzburg & Ellers, 919 Market Street
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
Genetic Technologies Limited v. Natera Inc.
Genetic Technologies Limited v. HistoGenetics LLC
Genetic Technologies Limited v. Natera Inc.
Genetic Technologies Limited v. Genetics & IVF Institute, Inc.
Genetic Technologies Limited v. Bristol-Myers Squibb Company
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5612179
Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
|
Filed: 1992-09-23
Issued: 1997-03-18
|
Expired (Term Ended)
Expires: 2012-09-23
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).